PFM
ALXO icon

Privium Fund Management’s ALX Oncology ALXO Stock Holding History

Privium Fund Management’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-509,059
Closed -$932K – 60
2025
Q3 		$932K Hold
509,059
– – 0.17% 43
2025
Q2 		$221K Hold
509,059
– – 0.05% 53
2025
Q1 		$317K Hold
509,059
– – 0.08% 50
2024
Q4 		$850K Hold
509,059
– – 0.19% 36
2024
Q3 		$926K Buy
509,059
+112,093
+28% +$417K 0.23% 35
2024
Q2 		$2.27M Buy
+396,966
New +$4.88M 0.58% 32

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Privium Fund Management's ALXO Position: Q4 2025 in Review

Privium Fund Management sold out of ALX Oncology (ALXO) in Q4 2025, closing a stake of 509,059 shares — an estimated $932K sold.

Privium Fund Management first reported a position in ALXO in Q2 2024 and held it in 6 quarters. The position peaked at $2.27M in Q2 2024. 57 funds tracked by Wall St. Rank hold ALXO as of Q4 2025.

  • Privium Fund Management reported no remaining ALX Oncology position as of Q4 2025 after selling out during the quarter.
  • Privium Fund Management sold 509,059 ALX Oncology shares in Q4 2025, an estimated $932K.
  • Privium Fund Management first reported a position in ALX Oncology in Q2 2024 and held it in 6 quarters.
  • Privium Fund Management's ALX Oncology position peaked at $2.27M in Q2 2024.
  • 57 funds tracked by Wall St. Rank held ALX Oncology as of Q4 2025.

Based on Privium Fund Management's 13F filing for Q4 2025, filed 3 Feb 2026.